Curaleaf Holdings, Inc.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment includes the production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how and back office administration, intellectual property licensing, real estate leasing services and lending facilities to medical and adult-use cannabis licensees under management service agreements. The company was founded on November 13, 2014 and is headquartered in New York, NY.

Anheuser-Busch InBev

GW Pharmaceuticals

Tilray Brands

The U.S. Food and Drug Administration's consumer update on CBD isn't the death knell it's made out to be.

4 Things to Know About the FDA's CBD Guidance

Green Thumb Industries Inc.

The Land of Lincoln could be generating more than $1.1 billion in annual weed sales by 2024, but there are plenty of risks, too.

4 Cannabis Stocks to Play Illinois' Budding Marijuana Market

Joe Bayern also has prior experience in the cannabis sector.

Curaleaf Taps Consumer Goods Veteran as New President

Curaleaf Holdings, Inc. (CSE: CURA) (OTC: CURLF) said Monday that Joe Bayern would take the position of president of the company, effective immediately.

Curaleaf Appoints Joe Bayern As President

Aphria

Trulieve Cannabis Corp.

These pot stocks are handily outselling two of the most popular names in cannabis.

4 Marijuana Stocks With Higher Sales Than Aurora or Canopy in the Latest Quarter

Aurora Cannabis

Canopy Growth

Cronos Group

Marijuana stock market caps continue to shrink.

There Are Only 9 Billion-Dollar Pot Stocks Left

These cannabis pure-plays all gained at least 10% in an otherwise awful month for pot stocks.

The 6 Best Marijuana Stocks in November

Not every pot stock floundered in November. These three delivered solid double-digit percentage gains.

3 Best Marijuana Stocks in November -- Are They Buys Now?

The Food and Drug Administration cautions that "CBD has the potential to harm you" in a newly released consumer update.

The FDA's Stance on CBD Should Surprise No One

The Wolverine State plans to open its doors to adult-use cannabis sales four months earlier than expected.

Recreational Weed Sales to Begin in Michigan in 8 Days

Vertically integrated cannabis company Curaleaf Holdings, Inc. (CSE: CURA) (OTC: CURLF) reported Tuesday its record quarterly pro forma revenue of $129 million for the third quarter of 2019.

Curaleaf Posts Record Q3 Pro Forma Revenue of $129M

The U.S. cannabis company's pending acquisitions could lead to these Q3 records being broken soon.

Why Curaleaf Holdings' Revenue Soared to All-Time Highs in Q3

Curaleaf Holdings, Inc. (CURLF) CEO Joe Lusardi on Q3 2019 Results - Earnings Call Transcript

The company met revenue expectations, but missed slightly on the bottom line.

Curaleaf Q3 Results Drive Down Stock Nearly 5%

Curaleaf Holdings Inc. CURLF, -4.86% CURA, -5.81% late Tuesday reported a narrower-than-expected loss but revenue that fell short of consensus estimates.

Cannabis producer Curaleaf revenue tops analyst expectations

Hundreds of banks across the country currently provide services to cannabis companies.

Cannabis Companies Are Still Getting Help From Banks, Even Without the SAFE Banking Act

CannTrust Holdings

An ETF could be a safer way to invest in the industry, but whether it's worth your money is an entirely different issue.

Does a Marijuana ETF Belong in Your Portfolio?

MedMen Enterprises Inc.

Once blazing hot, the appetite for cannabis mergers and acquisitions has cooled considerably in the United States.

Marijuana M&A Deals Are a Mess in the U.S.

It could take years for the Food and Drug Administration to produce a regulatory framework for CBD.

CBD Is Not Safe, Says Former FDA Chief Scott Gottlieb

Greenlane Holdings

HEXO Corp

Akerna Corp

Amplify Alternative Harvest ETF

OrganiGram Holdings Inc.

SNDL Inc.

Are marijuana stocks on U.S. exchanges a good buy now?

Are These Marijuana Stocks A Good Buy Now? Look Past The Hype

There's no indication that it's an industry-wide problem.

Why Vaping Deaths Aren't Likely to Hurt the Cannabis Industry

The company continues to build out the leading dispensary network in the U.S.

Curaleaf Opens First Recreational-Use Dispensary in Massachusetts

Curaleaf Holdings, Inc. (OTC: CURLF) (CSE: CURA) launched its first adult-use dispensary in Massachusetts with the Monday opening of its Oxford location.

Curaleaf Opens First Adult-Use Dispensary In Massachusetts

The past year has been a hectic one for cannabis stocks, particularly in Canada.

5 Big Surprises That Rocked the Cannabis Industry This Year

It's time to face the facts: Marijuana companies have been grossly overpaying for their acquisitions.

Curaleaf's Pending Purchase Signals Doom for Previous Cannabis Acquisitions

News for Curaleaf Holdings, Inc. Stock (CURLF)